The 4i platform provides ETC participants with a secure and efficient way to receive notifications about their attributed beneficiaries, Modality Performance Score, and Performance Payment Adjustment.
The Center for Medicare & Medicaid Services Innovation Center (CMMI) has launched a new web-based platform, 4Innovation (4i), to provide Measurement Year (MY) One End-Stage Renal Disease (ESRD) Treatment Choices (ETC) participants with a secure and efficient way to receive notifications about their attributed beneficiaries, Modality Performance Score (MPS), and Performance Payment Adjustment (PPA) for a PPA Period no later than one month before the start of the applicable PPA Period.
Through the most recent ESRD Prospective Payment System (PPS) annual rulemaking, CMS finalized regulations at §512.390(b) stating that the “form and manner” will be via a web-based platform, and CMS will provide ETC Participants further information about this web-based platform via the ETC listserv and ETC Model website at least one month before the first PPA Period begins on June 1, 2022.
The 4i platform requires an email address so that ETC Participants may access and receive reports. CMS is collecting email addresses and basic contact information. If you are or believe you are an ETC Participant (start date: 1/1/2021), please fill out the following survey as soon as possible: https://cms.gov1.qualtrics.com/jfe/form/SV_57I1CBBmxUWSpam.
The ETC Model Team is available to answer questions or provide further information via ETC-CMMI@cms.hhs.gov.
© 2021 American Society of Nephrology | All Rights Reserved
Powered by: PubFactory